EUCTR2005-006189-32-AT进行中（未招募）不适用
Clinical evaluation study: Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal(Klinische Evaluierungsstudie: Bupropion versus Psychodynamisches Mentaltraining nach Dr. Grohs zur Raucherentwöhnung - Bupropion vs. PDM zur Raucherentwöhnung
Steiermärkische Gebietskrankenkasse0 个研究点开始时间: 2006年2月1日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •nicotine addiction
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •mental illness, psychiatric diagnosis (except nicotine or caffeine addiction)
- •for Zyban: idiosyncrasy, epilepsy, bulimia, anorexia, zirrhosis, simultanous intake of MAO-inhibitors, brain tumour, alcohol or sedatives detoxication, pregnancy, nursing.
研究者
相似试验
已完成
2 期
Comparison of effect of bupropion and venlafaxine in children with hyperactivityAttention deficit hyperactivity disorder.Attention deficit: disorder with hyperactivity, hyperactivity disorder and syndrome with hyperactivityF90.0, F90IRCT201306189175N5Vice chancellor for research, Mashhad University of Medical Sciences40
已完成
不适用
Comparing the effects of Bupropion and Buprenorphine on the reduction of Methamphetamine cravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine : dependence syndromeF 15.2IRCT2015010320540N1Vice Chancellor for research of Shiraz University of Medical Sciences60
招募中
3 期
Effect of buprenorphine on the treatment of psychosis in bipolar patients with psychotic symptomsIRCT20190905044703N1Kerman University of Medical Sciences60
招募中
2 期
Comparison of bupropion, fluoxetine, and methylphenidate in cancer-related fatigueIRCT20180623040193N3Shahre-kord University of Medical Sciences60
尚未招募
3 期
Comparing how two different doses of an additive to bupivacaine heavy modifies the duration of action when used in lower limb surgeriesCTRI/2022/01/039545Dr Ashik Sreekumar